Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00877708|
Recruitment Status : Completed
First Posted : April 8, 2009
Last Update Posted : June 14, 2018
The purpose of this study is to review patients with E. coli infections at UPMC from September 1, 2008 to August 31, 2010 to determine if these infections have arisen in the community rather than in hospitals or nursing homes and determine their clinical outcomes.
The specific aims of this study are to:
- Review whether cephalosporin-resistant E. coli infections are hospital-acquired, healthcare-associated or community-associated.
- Determine the clinical outcome of the patients according to the antibiotics given.
|Condition or disease|
|E Coli Infections|
|Study Type :||Observational|
|Actual Enrollment :||150 participants|
|Official Title:||Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol|
|Actual Study Start Date :||March 2009|
|Actual Primary Completion Date :||December 2017|
|Actual Study Completion Date :||December 2017|
- dead or alive [ Time Frame: end of study ]health status
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00877708
|United States, Pennsylvania|
|Pittsburgh, Pennsylvania, United States, 15213|
|Principal Investigator:||Yohei Doi, MD||University of Pittsburgh|